MD lawrence i karsh

All Stories

1. 
   Data from Combination Treatment with Sipuleucel-T and Abiraterone Acetate or Enzalutamide for Metastatic Castration-Resistant Prostate Cancer: STAMP and STRIDE Trials

   Article • September 2024, American Association for Cancer Research (AACR)

   MD lawrence i karsh

2. 
   Data from Combination Treatment with Sipuleucel-T and Abiraterone Acetate or Enzalutamide for Metastatic Castration-Resistant Prostate Cancer: STAMP and STRIDE Trials

   Article • September 2024, American Association for Cancer Research (AACR)

   MD lawrence i karsh

3. 
   Supplementary Data 1 from Combination Treatment with Sipuleucel-T and Abiraterone Acetate or Enzalutamide for Metastatic Castration-Resistant Prostate Cancer: STAMP and STRIDE Trials

   Article • September 2024, American Association for Cancer Research (AACR)

   MD lawrence i karsh

4. 
   Supplementary Data 1 from Combination Treatment with Sipuleucel-T and Abiraterone Acetate or Enzalutamide for Metastatic Castration-Resistant Prostate Cancer: STAMP and STRIDE Trials

   Article • September 2024, American Association for Cancer Research (AACR)

   MD lawrence i karsh

5. 
   Supplementary Fig. 1 from Combination Treatment with Sipuleucel-T and Abiraterone Acetate or Enzalutamide for Metastatic Castration-Resistant Prostate Cancer: STAMP and STRIDE Trials

   Article • September 2024, American Association for Cancer Research (AACR)

   MD lawrence i karsh

6. 
   Supplementary Fig. 1 from Combination Treatment with Sipuleucel-T and Abiraterone Acetate or Enzalutamide for Metastatic Castration-Resistant Prostate Cancer: STAMP and STRIDE Trials

   Article • September 2024, American Association for Cancer Research (AACR)

   MD lawrence i karsh

7. 
   Supplementary Fig. 2 from Combination Treatment with Sipuleucel-T and Abiraterone Acetate or Enzalutamide for Metastatic Castration-Resistant Prostate Cancer: STAMP and STRIDE Trials

   Article • September 2024, American Association for Cancer Research (AACR)

   MD lawrence i karsh

8. 
   Supplementary Fig. 2 from Combination Treatment with Sipuleucel-T and Abiraterone Acetate or Enzalutamide for Metastatic Castration-Resistant Prostate Cancer: STAMP and STRIDE Trials

   Article • September 2024, American Association for Cancer Research (AACR)

   MD lawrence i karsh

9. 
   Supplementary Fig. 3 from Combination Treatment with Sipuleucel-T and Abiraterone Acetate or Enzalutamide for Metastatic Castration-Resistant Prostate Cancer: STAMP and STRIDE Trials

   Article • September 2024, American Association for Cancer Research (AACR)

   MD lawrence i karsh

10. 
    Supplementary Fig. 3 from Combination Treatment with Sipuleucel-T and Abiraterone Acetate or Enzalutamide for Metastatic Castration-Resistant Prostate Cancer: STAMP and STRIDE Trials

    Article • September 2024, American Association for Cancer Research (AACR)

    MD lawrence i karsh

11. 
    Data from Combination Treatment with Sipuleucel-T and Abiraterone Acetate or Enzalutamide for Metastatic Castration-Resistant Prostate Cancer: STAMP and STRIDE Trials

    Article • July 2023, American Association for Cancer Research (AACR)

    MD lawrence i karsh

12. 
    Supplementary Data 1 from Combination Treatment with Sipuleucel-T and Abiraterone Acetate or Enzalutamide for Metastatic Castration-Resistant Prostate Cancer: STAMP and STRIDE Trials

    Article • July 2023, American Association for Cancer Research (AACR)

    MD lawrence i karsh

13. 
    Supplementary Data 1 from Combination Treatment with Sipuleucel-T and Abiraterone Acetate or Enzalutamide for Metastatic Castration-Resistant Prostate Cancer: STAMP and STRIDE Trials

    Article • July 2023, American Association for Cancer Research (AACR)

    MD lawrence i karsh

14. 
    Supplementary Fig. 1 from Combination Treatment with Sipuleucel-T and Abiraterone Acetate or Enzalutamide for Metastatic Castration-Resistant Prostate Cancer: STAMP and STRIDE Trials

    Article • July 2023, American Association for Cancer Research (AACR)

    MD lawrence i karsh

15. 
    Supplementary Fig. 1 from Combination Treatment with Sipuleucel-T and Abiraterone Acetate or Enzalutamide for Metastatic Castration-Resistant Prostate Cancer: STAMP and STRIDE Trials

    Article • July 2023, American Association for Cancer Research (AACR)

    MD lawrence i karsh

16. 
    Supplementary Fig. 2 from Combination Treatment with Sipuleucel-T and Abiraterone Acetate or Enzalutamide for Metastatic Castration-Resistant Prostate Cancer: STAMP and STRIDE Trials

    Article • July 2023, American Association for Cancer Research (AACR)

    MD lawrence i karsh

17. 
    Supplementary Fig. 2 from Combination Treatment with Sipuleucel-T and Abiraterone Acetate or Enzalutamide for Metastatic Castration-Resistant Prostate Cancer: STAMP and STRIDE Trials

    Article • July 2023, American Association for Cancer Research (AACR)

    MD lawrence i karsh

18. 
    Supplementary Fig. 3 from Combination Treatment with Sipuleucel-T and Abiraterone Acetate or Enzalutamide for Metastatic Castration-Resistant Prostate Cancer: STAMP and STRIDE Trials

    Article • July 2023, American Association for Cancer Research (AACR)

    MD lawrence i karsh

19. 
    Supplementary Fig. 3 from Combination Treatment with Sipuleucel-T and Abiraterone Acetate or Enzalutamide for Metastatic Castration-Resistant Prostate Cancer: STAMP and STRIDE Trials

    Article • July 2023, American Association for Cancer Research (AACR)

    MD lawrence i karsh

20. 
    Data from Combination Treatment with Sipuleucel-T and Abiraterone Acetate or Enzalutamide for Metastatic Castration-Resistant Prostate Cancer: STAMP and STRIDE Trials

    Article • May 2023, American Association for Cancer Research (AACR)

    MD lawrence i karsh

21. 
    Supplementary Data 1 from Combination Treatment with Sipuleucel-T and Abiraterone Acetate or Enzalutamide for Metastatic Castration-Resistant Prostate Cancer: STAMP and STRIDE Trials

    Article • May 2023, American Association for Cancer Research (AACR)

    MD lawrence i karsh

22. 
    Supplementary Data 1 from Combination Treatment with Sipuleucel-T and Abiraterone Acetate or Enzalutamide for Metastatic Castration-Resistant Prostate Cancer: STAMP and STRIDE Trials

    Article • May 2023, American Association for Cancer Research (AACR)

    MD lawrence i karsh

23. 
    Supplementary Fig. 1 from Combination Treatment with Sipuleucel-T and Abiraterone Acetate or Enzalutamide for Metastatic Castration-Resistant Prostate Cancer: STAMP and STRIDE Trials

    Article • May 2023, American Association for Cancer Research (AACR)

    MD lawrence i karsh

24. 
    Supplementary Fig. 1 from Combination Treatment with Sipuleucel-T and Abiraterone Acetate or Enzalutamide for Metastatic Castration-Resistant Prostate Cancer: STAMP and STRIDE Trials

    Article • May 2023, American Association for Cancer Research (AACR)

    MD lawrence i karsh

25. 
    Supplementary Fig. 2 from Combination Treatment with Sipuleucel-T and Abiraterone Acetate or Enzalutamide for Metastatic Castration-Resistant Prostate Cancer: STAMP and STRIDE Trials

    Article • May 2023, American Association for Cancer Research (AACR)

    MD lawrence i karsh

26. 
    Supplementary Fig. 2 from Combination Treatment with Sipuleucel-T and Abiraterone Acetate or Enzalutamide for Metastatic Castration-Resistant Prostate Cancer: STAMP and STRIDE Trials

    Article • May 2023, American Association for Cancer Research (AACR)

    MD lawrence i karsh

27. 
    Supplementary Fig. 3 from Combination Treatment with Sipuleucel-T and Abiraterone Acetate or Enzalutamide for Metastatic Castration-Resistant Prostate Cancer: STAMP and STRIDE Trials

    Article • May 2023, American Association for Cancer Research (AACR)

    MD lawrence i karsh

28. 
    Supplementary Fig. 3 from Combination Treatment with Sipuleucel-T and Abiraterone Acetate or Enzalutamide for Metastatic Castration-Resistant Prostate Cancer: STAMP and STRIDE Trials

    Article • May 2023, American Association for Cancer Research (AACR)

    MD lawrence i karsh

29. 
    Combination Treatment with Sipuleucel-T and Abiraterone Acetate or Enzalutamide for Metastatic Castration-Resistant Prostate Cancer: STAMP and STRIDE Trials

    Article • Clinical Cancer Research, April 2023, American Association for Cancer Research (AACR)

    MD lawrence i karsh

30. 
    Talazoparib plus enzalutamide in metastatic castration-resistant prostate cancer: TALAPRO-2 phase III study design

    Article • Future Oncology, January 2022, Taylor & Francis

    MD lawrence i karsh

31. 
    Optimizing the management of castration‐resistant prostate cancer patients: A practical guide for clinicians

    Article • The Prostate, August 2020, Wiley

    MD lawrence i karsh

32. 
    Intramuscular depot formulations of leuprolide acetate suppress testosterone <20 ng/dL threshold

    Article • Research and Reports in Urology, August 2016, Dove Medical Press

    MD lawrence i karsh